Get the Stockscreener App
1.05
0.94%
-0.01
Cocrystal Pharma Inc stock is traded at $1.05, with a volume of 48,551.
It is down -0.94% in the last 24 hours and down -4.55% over the past month.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
See More
Previous Close:
$1.06
Open:
$1.07
24h Volume:
48,551
Relative Volume:
0.03
Market Cap:
$14.47M
Revenue:
-
Net Income/Loss:
$-17.93M
P/E Ratio:
-0.5932
EPS:
-1.77
Net Cash Flow:
$-14.28M
1W Performance:
+2.94%
1M Performance:
-4.55%
6M Performance:
-31.82%
1Y Performance:
-43.55%
1-Day Range:
$1.04
$1.078
1-Week Range:
$1.02
$1.10
52-Week Range:
$0.90
$3.26
Cocrystal Pharma Inc Stock (COCP) Company Profile
Name
Cocrystal Pharma Inc
Sector
Industry
Phone
(786) 459-1831
Address
19805 N. CREEK PARKWAY, BOTHELL, WA
Compare COCP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COCP
Cocrystal Pharma Inc
|
1.05 | 14.61M | 0 | -17.93M | -14.28M | -1.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-08-20 | Initiated | H.C. Wainwright | Buy |
Cocrystal Pharma Inc Stock (COCP) Latest News
Revenue per share of Cocrystal Pharma Inc – FWB:8CC - TradingView
Why institutional investors increase stakes in Cocrystal Pharma Inc. (8CC) stockJuly 2025 Review & AI Optimized Trade Strategies - Newser
Published on: 2025-12-02 05:48:00 - Newser
How Cocrystal Pharma Inc. (8CC) stock valuation compares with sectorBond Market & Reliable Price Breakout Signals - Newser
How Cocrystal Pharma Inc. (8CC) stock behaves under inflation pressureWeekly Market Summary & Weekly High Return Opportunities - Newser
Is Cocrystal Pharma Inc. (8CC) stock among top earnings playsMarket Risk Analysis & Expert-Curated Trade Recommendations - Newser
Cocrystal Pharma to Present at Emerging Growth Conference - TipRanks
Cocrystal Pharma to Present at Noble Capital Markets Conference - TradingView
COCP Insider Trading - Quiver Quantitative
Cocrystal Pharma, Inc. to Present Clinical Progress Update at NobleCon 21 Conference - Quiver Quantitative
Cocrystal Pharma to Present at the Noble Capital Markets’ 21st Emerging Growth Equity Conference - marketscreener.com
Cocrystal Pharma (Nasdaq: COCP) to present company overview at NobleCon 21 on Dec. 3, 2025 - Stock Titan
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $3975 By Investing.com - Investing.com South Africa
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $3975 - Investing.com
Tuesday’s Insider Activity: Major Buys at CBC, COCP; Sells at ARES, RKLB By Investing.com - Investing.com South Africa
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812 - Investing.com India
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812 By Investing.com - Investing.com Australia
COCP insider Phillip Frost updates holdings after 20,000-share trade - Stock Titan
What analysts say about Cocrystal Pharma Inc 8CC stockSector-Based Investing & High Profit Trading Alerts - earlytimes.in
Zacks Small Cap Has Bullish Outlook for COCP FY2025 Earnings - Defense World
Cocrystal Pharma Inc. (COCP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Cocrystal Pharma Inc. stock vulnerable to regulatory risksWeekly Stock Analysis & Real-Time Buy Zone Alerts - newser.com
Is Cocrystal Pharma Inc. stock a top momentum playPortfolio Value Report & Risk Managed Trade Strategies - newser.com
Can Cocrystal Pharma Inc. (8CC) stock sustain double digit ROEJuly 2025 PreEarnings & Weekly Breakout Opportunity Watchlist - newser.com
Why Cocrystal Pharma Inc. (8CC) stock remains stableJuly 2025 Sector Moves & Low Risk High Win Rate Stock Picks - newser.com
Is Cocrystal Pharma Inc. stock attractive for long term wealth buildingMarket Activity Recap & Verified Entry Point Signals - newser.com
Does Cocrystal Pharma Inc. qualify in momentum factor screeningQuarterly Trade Summary & Intraday High Probability Alerts - newser.com
Will Cocrystal Pharma Inc. stock pay special dividends2025 Bull vs Bear & High Accuracy Trade Signal Alerts - newser.com
Can Cocrystal Pharma Inc. stock sustain revenue growthWeekly Gains Report & Community Consensus Trade Alerts - newser.com
Can Cocrystal Pharma Inc. stock maintain operating margins2025 Short Interest & Risk Adjusted Swing Trade Ideas - newser.com
Can machine learning forecast Cocrystal Pharma Inc. recovery2025 Market Overview & Fast Exit/Entry Strategy Plans - newser.com
Cocrystal Pharma Inc Stock (COCP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cocrystal Pharma Inc Stock (COCP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | Director |
Nov 25 '25 |
Buy |
0.94 |
20,000 |
18,812 |
1,699,551 |
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):